NUVL Q3 2025 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$113M

Net Income

-$122M

EPS (Diluted)

$-1.70

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$70M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$980M

Total Liabilities

$135M

Stockholders' Equity

$845M

Cash & Equivalents

$116M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$113M	-$76M	-47.6%
Net Income	-$122M	-$84M	-45.2%